How long should we treat Candida albicans pyomyositis? Insight from a cured case
Journal
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Journal Volume
53
Journal Issue
4
Date Issued
2020-08
Author(s)
Subjects
Candida albicans; Fungal pyomyositis; Upper extremity
Other Subjects
anidulafungin; cephalosporin; creatinine; fluconazole; hemoglobin; micafungin; sultamicillin; antifungal agent; abscess; adult; antifungal therapy; arm swelling; blood culture; candidemia; candidiasis; case report; clinical article; computer assisted tomography; creatinine blood level; deltoid muscle; emergency ward; erythema; Escherichia coli; fine needle aspiration biopsy; follow up; hemoglobin blood level; hepatitis B; hospital discharge; hospitalization; human; human tissue; infraspinatus muscle; Letter; leukocyte count; male; medical history; middle aged; non insulin dependent diabetes mellitus; nuclear magnetic resonance imaging; physical examination; pyomyositis; recurrent disease; shoulder disease; supraspinatus muscle; surgical debridement; treatment duration; urinary tract infection; wound care; wound closure; wound drainage; arm; Candida albicans; candidiasis; debridement; drug effect; isolation and purification; microbiology; pathology; pyomyositis; time factor; treatment outcome; Antifungal Agents; Arm; Candida albicans; Candidiasis; Debridement; Humans; Male; Middle Aged; Pyomyositis; Recurrence; Time Factors; Treatment Outcome
Type
letter